[Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
OBJECTIVE
To observe the effects of ginsenosides (GS) and low dose glucocorticoid for preventing and treating the post-transcatheter arterial chemoembolization (TACE) syndrome.


METHODS
Adopting randomized, double blinded, controlled method, 80 patients with primary liver cancer were divided into 4 groups, placebo group, dexamethasone (Dex) group, Ginsenosides (GS) group, and Dex combined with GS group to observe the clinical effect of the patients after TACE.


RESULTS
Dex combined with GS could markedly lower the occurrence of nausea, vomiting, fever and pain, and the median time of symptoms persistence, also alleviate the bone marrow inhibition of chemotherapy.


CONCLUSIONS
Dex combined with GS could effectively prevent and treat TACE syndrome.
Feng
Ying-Lu
YL
Department of TCM, Changhai Hospital, The Second Military Medical Univirsity, Shanghai.
Ling
Chang-Quan
CQ
Li
Bai
B
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000139:chemically induced; D036145:Ginsenosides / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D013577:Syndrome; D014839:Vomiting / Q000139:chemically induced
D004365:Drugs, Chinese Herbal; D036145:Ginsenosides; D003907:Dexamethasone